Hardware Tiering and AI Coaching: How Google's Fitbit Edge Reshapes Continuous Monitoring Economics
Dr. Dereck Mush, MD, MBA
InflammaSense
Develops the VITALx-patch wearable, measuring autonomic and physiological signals for research into inflammatory and immune states.
What they do
InflammaSense is a UC San Diego incubated company developing the VITALx-patch, a wearable that measures autonomic, neural and physiological signals for research into inflammatory and immune states. It is a performer on the University of Vermont led, ARPA-H funded ReSCUED project on digital twins for critical illness, with an award of up to $3.9 million. Co-founders are Imanuel Lerman, MD, MS (CEO) and Rahul Singh, PhD (CTO). The technology is under development for research use and is not an established clinical diagnostic.
The record
- Vertical
- Remote Monitoring & Wearables
- Sub-segment
- Wearable inflammatory monitoring
- Product type
- Device
- Stage
- Headquarters
- San Diego, United States
- Region
- North America
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Remote Monitoring & Wearables
Related on The Signal
Dr. Dereck Mush, MD, MBA
Wearable cardiac monitoring is catching arrhythmias in men who would never have scheduled the test that found them
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The Top Remote Patient Monitoring Platforms of 2026
A hospital bed is the most expensive real estate in medicine. These seven platforms are moving serious care into the living room, and getting paid for it.
Dr. Dereck Mush, MD, MBA
From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA